How a Fitness Brand Built a Peptide Revenue Channel

Core Insights

Introduction

A fitness and performance brand with a loyal online community had been selling supplements for three years. The audience was engaged, evidence-driven, and had the disposable income to act. Peptide interest had been building organically in the community — BPC-157 questions, recovery protocol threads — without any direct brand promotion.

Several posts about peptide-supported recovery generated more engagement than any product launch in the previous 12 months. The operator wanted to convert that organic demand into a compliant revenue channel without pivoting away from supplements or adding clinical headcount.

Daniel Meursing

CEO

Daniel is a two-time founder who has scaled service businesses across major U.S. markets. A Y Combinator competition winner, he focuses on removing operational and regulatory barriers so operators can build and scale modern healthcare businesses. :

Background

Startup Operations & Service Systems

Experience

2x Founder, Multi-Market U.S. Scaling

Qualifications

Healthtech Infrastructure & Patient Access

Key Achievement

Scaled Premier Staff & Eventstaff across major U.S. markets

The Challenge

The brand had no experience with prescription products. Peptides prescribed through a telehealth workflow require provider credentialing, compounding pharmacy relationships, HIPAA infrastructure, and async clinical review — a completely different operational category from supplements. Getting this wrong publicly would have damaged three years of audience trust. The second constraint was margin. Supplement margins are high. Any clinical program needed to meet or exceed that profile to justify the additional complexity — requiring pricing and fee structure confirmation before any program design began.

Step 1 — Program Category Selection

The operator worked with FuseHealth to identify which peptide categories were available within the configured provider network and compounding pharmacy standing — specifically compounds with the highest relevance to the performance and recovery audience, validated by existing community engagement data.

Step 2 — Intake and Qualification

The intake form qualified patients for the specific peptide protocols in sufficient depth to enable efficient async provider review — minimizing back-and-forth that drives up provider costs and erodes program margin.

Step 3— Community-First Launch

The program launched to the existing community before any paid acquisition spend. The first cohort came entirely from warm organic channels, validating pricing and program structure before paid budget was committed.

Validated Program Pricing — Margin was confirmed against platform fees before launch. Pricing held through the first cohort without adjustment.

Community-First Revenue — The first cohort came entirely from existing community members. Customer acquisition cost on the first cohort was near zero.

90-Day Protocol Structure — Protocol-based programs create commitment at enrollment, driving meaningfully higher retention than open-ended subscriptions.

Blended LTV Increase — Peptide subscribers maintained supplement purchase behavior, increasing total annual spend per customer.

Build Your Telehealth Platform Faster

Launching digital healthcare services requires complex infrastructure. Fuse provides the tools needed to connect patients, providers, and pharmacies in one platform.

Step 4 — Subscription and Margin Design

Programs were structured as 90-day protocols with monthly refill billing, priced above the supplement average order value. Margin was confirmed against the FuseHealth fee structure before launch. No pricing adjustments were needed after the first cohort enrolled.

What Launched

The peptide program launched within six weeks of the initial FuseHealth onboarding. The first cohort was entirely from existing community members with no paid acquisition spend. Monthly recurring revenue from the program exceeded the best supplement product launch in the brand's history within 90 days.

Core Insights

The peptide program launched six weeks after onboarding began. Monthly recurring revenue exceeded the best supplement product launch in the brand's history within 90 days.

The brand did not hire any clinical staff. Prescription review, pharmacy fulfillment, and refill management ran through FuseHealth. The operator managed the community and acquisition strategy.

Refrences

American Med Spa Association Industry Report (2025) · FDA Compounding Pharmacy Guidance (2024–2025) · McKinsey & Company Consumer Health Survey (2024) · Wheel Virtual Care Report (2024)